⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FATE News
Fate Therapeutics, Inc.
Form 8-K
sec.gov
FATE
Fate Therapeutics Appoints Laura Hamill to Board of Directors
globenewswire.com
FATE
After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell
globenewswire.com
GTBP
FATE
NKTX
CMPX
CRBU
Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet
globenewswire.com
IOVA
GTBP
NKTX
IBRX
FATE
Form 8-K
sec.gov
FATE
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
globenewswire.com
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting
globenewswire.com
FATE
The $13 Million Company Teaching the Immune System to Hunt Cancer
prnewswire.com
NKTX
GTBP
IBRX
FATE
ARTV
Fate Therapeutics Announces Presentations at 2026 ASCO and EULAR Annual Meetings Highlighting Off-the-Shelf CAR T-cell Therapy Pipeline for Cancer and Autoimmune Diseases
globenewswire.com
FATE